|
|
 admin  星期五, 1st of 四月 2011 at 01:27:37 上午  (English) Probably, given that most CHM were developed in a different medical theoretical system in China, the approved herbal drugs currently used in China will need further R&D before they can be safely used in the EU member states. For pharmaceutical companies in both China and EU Member States developing new herbal medicines, what industrial and legal criteria should be observed so that their products will be approvable in both Continents? WP7 will investigate if functional genomics may provide an additional and efficient component of the approval procedures of CHM for the EU …more
admin 星期二, 22nd of 二月 2011 at 01:44:21 下午
 (English) The study will help defining the different factors that influence the perceptions of quality and safety of herbal medicines, notably …more
admin 星期四, 10th of 二月 2011 at 02:39:06 下午
 (English) How to report experimental work according to good …more
admin 星期三, 2nd of 二月 2011 at 01:35:53 下午
 (English) Electronic survey to help to inform about training, practice and common conditions treated by TCM …more
admin 星期三, 2nd of 二月 2011 at 01:31:20 下午
 (English) The joint phase III meeting of WP1 and WP2 was held in Braga, Portugal on 3rd – 4th December …more
admin 星期三, 2nd of 二月 2011 at 01:30:53 下午
 (English) Genesis is reputed to be the leading biotechnology networking event in …more
admin 星期三, 2nd of 二月 2011 at 01:12:10 下午
 (English) This issue celebrates the Year of the …more
admin 星期三, 5th of 一月 2011 at 02:50:13 下午
 (English) Merry Christmas from GP-TCM! China invests 4 billion RMB in constructing 16 National Clinical Research Bases of TCM, WHO moves to classify traditional …more
admin 星期四, 18th of 十一月 2010 at 12:54:45 下午
 (English) New EU Strategies and Policies, Revisiting UK’s Seed Cathedral in Shanghai 2010 World Expo …more
admin 星期二, 7th of 九月 2010 at 02:14:53 下午
 (English) 1st GP-TCM Annual Meeting, Joint WP1 – WP2 Phase II Kick-off Meeting, Joint WP4 – WP7 Phase II Kick-off Meeting …more
|
|